Decibel Therapeutics Hires Biogen Exec Steven Holtzman as New CEO

Xconomy Boston — 

Decibel Therapeutics has hired Steven Holtzman, a former Biogen executive, as its president and chief executive officer. Holtzman has had a long career in executive roles, including as CEO and board director at Infinity Pharmaceuticals and the chief business officer of Millennium Pharmaceuticals. Holtzman most recently came from the role of executive vice president for business operations at Biogen. Cambridge, MA-based Decibel launched in October 2015 with a $52 million Series A from Third Rock Ventures and SR One.